drugset / Trial / NCT00575393

Gold Sodium Thiomalate in Treating Patients With Advanced Non-Small Cell Lung Cancer

NCT00575393

Phase 1 Completed 17 enrolled Mayo Clinic
Treatment

Summary

RATIONALE: Gold sodium thiomalate may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of gold sodium thiomalate in treating patients with advanced non-small cell lung cancer.

Timeline

Start
2007-01-25
Primary completion
2011-06-30
Completion
2012-02-14

Drugs

EvaluationDrugModalityDoseRoute
Subject gold sodium thiomalate Small molecule Intramuscular

Indications